Regina Gowindah

Regina Gowindah

Auto-generated profile, based on publicly available information

Regina Gowindah

Oracle Life Sciences

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2024 in Human Vaccines & Immunotherapeutics
Verified
Journal Article
Open access
JCJing Chen
Jing Chen
SSSumitra Shantakumar
Sumitra Shantakumar
JSJennifer Si
Jennifer Si
RGRegina Gowindah
Regina Gowindah
RPRaunak Parikh
Raunak Parikh
AWAndrew Ty Wong
Andrew Ty Wong
Herpes zoster (HZ) is a prevalent disease characterized by a painful rash. A multi‑country study was conducted to elicit public and physician knowledge, attitude, and practice (KAP) toward HZ disease and vaccination for the assessment of local factors influencing HZ vaccine perceptions in four Asian-Pacific countries/territories One-to-one qualitative interviews were conducted in 2022, among the public (people aged ≥ 50 years, adults with parents aged ≥ 50 years, zoster vaccine live-vaccinated individuals aged ≥ 50 years in Republic of Korea, and HZ patients; n = 78) and physicians (general practitioners and specialists; n = 24). Themes surrounding KAP toward HZ and HZ vaccination were summarized using a thematic analysis. A substantial knowledge gap related to HZ was observed among the public, including its causes, long-term impacts, and the at-risk population. There was a low perceived risk of HZ and low general awareness of HZ vaccine availability, although country/territory-specific differences existed. Fear of HZ-associated pain contributed toward vaccination intent among HZ patients and adults with parents aged ≥ 50 years. HZ-naïve adults who were encouraged to receive the vaccine by others were not motivated to do so due to optimism bias. Physicians were perceived to be a reliable source of information. However, physicians did not always proactively discuss HZ vaccination due to time constraints and a perceived need to prioritize other vaccinations including influenza and pneumococcal vaccines. Initiatives are needed to improve public awareness of HZ and its complications, in terms of overall impact on individuals and society, and highlight the important role of physicians in recommending vaccination.

27 July 2021 in The Journal of Dermatology
Verified
Journal Article
Open access
PDF file
YTYayoi Tada
Yayoi Tada
SJSeong-Jin Jo
Seong-Jin Jo
YHYu‐Huei Huang
Yu‐Huei Huang
BWBryan Wahking
Bryan Wahking
BLBong Young Lee
Bong Young Lee
PFPablo Fernandez-Peñas
Pablo Fernandez-Peñas
Studies on the psychosocial and emotional burden of psoriasis have been extensive; however, there is limited knowledge and awareness of patients’ attitude and behavior towards psoriasis treatment. To understand psoriasis patients’ attitude and behavior towards treatment of psoriasis, especially those treated with biologics, a multi‐stage study qualitative and quantitative methodology was conducted among psoriasis patients. An online survey was conducted with 45 moderate‐to‐severe psoriasis patients each in Australia, Japan, South Korea, and Taiwan for 20 min. This was followed by qualitative in‐depth interviews conducted among psoriasis patients in Australia (n = 3) and Japan (n = 2) for 60 min. All of the findings were workshopped with key opinion leaders and patient advisory groups to identify potential solutions addressing patients’ unmet needs. Five common insights were identified across the region, highlighting patients’ attitude and behavior towards psoriasis treatment, especially for those treated with biologics. These insights comprised the following: (i) one of the key factors driving patients’ treatment choice included their ability to enjoy clear skin for longer period (68%); (ii) bio‐maintenance patients had a higher expectation (4.9 months) of how long their skin could stay clear, compared to their pre‐biologics initiation days (2.9 months); (iii) once a good response is achieved, bio‐maintenance patients were more concerned about symptoms returning (44%) than development of side‐effects (19%); (iv) bio‐maintenance patients felt psychologically and physically affected during flare‐ups despite being on more efficacious treatment; and (v) bio‐maintenance patients still felt they were at risk of flare‐ups (4.5/7), almost similar risk perception as non‐biologics patients (4.9/7). Findings from this study showed that psoriasis patients look for treatment with the least risk of flare‐ups so that they were able to enjoy clear skin for a long time.

1 September 2024 in JU Open Plus
Verified
Journal Article
Open access
BTBen Tran
Ben Tran
AMAtsushi Mizokami
Atsushi Mizokami
SWShian-Shiang Wang
Shian-Shiang Wang
YLYonghong Li
Yonghong Li
TTTsutomu Takeuchi
Tsutomu Takeuchi
HHHyunho Han
Hyunho Han
Purpose: To understand the impact of prostate cancer (PC) and identify gaps in existing care from patients, caregivers, and physicians in Australia, Japan, Mainland China, South Korea, and Taiwan. Materials and Methods: This study comprised qualitative interviews among patient-caregiver pairs and quantitative surveys among patients (high-risk localized [HRLPC] or metastatic castration-resistant [mCRPC]) and physicians. Thematic interpretation from qualitative interviews, to facilitate the quantitative survey development, was guided by the Psycho-Onco Emotional Anxiety (POEM) Framework and COM-B (Capability, Opportunity, Motivation-Behavior) model. Results: Patients reported experiencing high anxiety about fear of cancer recurrence (HRLPC: 83.3%; mCRPC: 88.9%), which increased along the course of their illness (68.8%; 48.1%). More mCRPC (40.7%) than HRLPC (20.8%) patients perceived delays in cancer diagnosis, with reasons related to time between consultation and diagnosis, belief that symptoms were not severe, prostate-specific antigen testing not a routine, or unaware of symptoms. More mCRPC (25.9%) than HRLPC (8.3%) were confused about treatment options, consistent with physicians' clinical observations. More mCRPC than HRLPC patients felt their physicians did not clearly explain potential treatment benefits, risks, and side effects or inform new therapies. Physicians (39.4%-49.5%) reported having insufficient consultation time to talk to patients. Despite majority of physicians (>80%) encouraging patients to make treatment decisions, 77.8% to 83.3% of patients relied on their doctors. Conclusions: Challenges to current PC care included gaps in knowledge, patient-physician communication, shared decision-making, and psychosocial support which are interrelated. There is a need for multidisciplinary efforts to boost patient awareness and psychosocial support to enhance the quality of comprehensive PC care.

1 November 2020 in Annals of Oncology
Verified
Journal Article
Closed access
PDF file
ACand Pierce KH Chow
and Pierce KH Chow
JBJ-F. Baladi
J-F. Baladi
YCYew Woon Yew Chia
Yew Woon Yew Chia
BRB. Ramaswamy
B. Ramaswamy
VGV. Grillo
V. Grillo
RGR. Gowindah
R. Gowindah

3 February 2026 in Human Vaccines & Immunotherapeutics
Verified
Journal Article
Open access
JCJing Chen
Jing Chen
SSSumitra Shantakumar
Sumitra Shantakumar
JSJennifer Si
Jennifer Si
RGRegina Gowindah
Regina Gowindah
VGVince Grillo
Vince Grillo
AWAndrew Ty Wong
Andrew Ty Wong
This study aimed to assess knowledge, attitudes, and practices toward herpes zoster (HZ) disease and vaccination and identify factors influencing HZ vaccination perceptions and behavior in adults ≥50 y of age (YOA) among the public and physicians in Hong Kong (HK), Singapore (SG), Republic of Korea (KR), and Taiwan (TW). A two-phase cross-sectional study was conducted in January-September 2022, including concept elicitation interviews (first phase, previously published) and a quantitative online survey (second phase, current article). The second phase involved a larger sample from the same target populations with different individuals. Participants in the second phase included: 1,970 adults ≥50 YOA, 203 adults aged 30-49 YOA with parents ≥50 YOA, and 220 physicians. Substantial knowledge gaps existed among the public about the causes, long-term impact, and risk factors for HZ. Awareness of HZ vaccine availability varied across locales (highest in KR [76%]; lowest in TW [35%]), and higher among individuals with a history of HZ (73%) than HZ-naïve individuals ≥50 YOA (49%). Key drivers of HZ vaccination included preventing disease/recurrence (44%) and long-term complications (41%), and physician recommendations (36%). Two-in-five individuals ≥50 YOA were recommended HZ vaccination. Most physicians agreed that recommending HZ vaccines to patients ≥50 YOA was important but reported initiating HZ vaccination conversations with 27.8% of their patients ≥50 YOA. Knowledge gaps surrounding HZ and HZ vaccination remain. Initiatives are needed to improve public awareness regarding the importance of HZ prevention. Physicians also play an important role in having proactive discussions about HZ prevention with their patients.